Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Effects of Resveratrol Supplementation on Liver Enzymes: A Systematic Review and Meta-Analysis of Randomised Controlled Trials Publisher Pubmed



Darand M1 ; Farrokhzad A2 ; Ghavami A1 ; Hadi A3 ; Karimi E1, 4 ; Fadel A5 ; Askari G6
Authors
Show Affiliations
Authors Affiliations
  1. 1. Student Research Committee, Department of Clinical Nutrition, School of Nutrition and Food Science, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Department of Orthopedics, Isfahan University of Medical Sciences, Isfahan, Iran
  3. 3. Halal Research Center of IRI, FDA, Tehran, Iran
  4. 4. Research Development Center, Arash Women’s Hospital, Tehran University of Medical Sciences, Tehran, Iran
  5. 5. School of Sport and Exercise Sciences, Liverpool John Moores University, Liverpool, United Kingdom
  6. 6. Department of Community Nutrition, School of Nutrition and Food Science, Food Security Research Center, Isfahan University of Medical Sciences, Isfahan, Iran

Source: International Journal of Clinical Practice Published:2021


Abstract

Background: The available evidence regarding the possible effects of resveratrol on liver function is inconsistent. Therefore, the present meta-analysis was performed to investigate the overall effects of resveratrol supplementation on liver enzymes in adults. Methods: A systematic and comprehensive search of the online medical databases including PubMed, Scupos, Web of Science and Cochran Library was performed up to February 2020. All RCTs using resveratrol supplements in adults were included in this systematic review and meta-analysis. The overall effect was presented as weighted mean difference (WMD) and 95% confidence interval (CI) in a random-effects meta-analysis model. Results: Finally, 15 randomised trials including 714 participants were selected for the present meta-analysis. Pooled analysis did not show any significant changes in alanine aminotransferase (ALT) (WMD: 0 IU/L, 95% CI: −3.17 to 3.17, P =.99; I2 = 74.2%), aspartate aminotransferase (AST) (WMD: −2.40 IU/L, 95% CI: −5.45 to 0.65, P =.11; I2 = 82.9%), gamma-glutamyl transferase (GGT) (WMD: −1.26 IU/L, 95% CI: −4.64 to 2.13, P =.64; I2 = 23.7%), alkaline phosphatase (ALP) (WMD: 3.80 IU/L, 95% CI: −4.65 to 12.25, P =.37; I2 = 29.9%) and bilirubin (WMD: 0.13 IU/L, 95% CI: −0.43 to 0.17, P =.39; I2 = 8.9%) after supplementation with resveratrol. Conclusion: Overall, in our study, resveratrol does not affect liver enzyme levels significantly, but subgroup analysis indicates that these results may be influenced by resveratrol dose, duration of the study and population status, so future high-quality studies are necessary to get definitive results. © 2020 John Wiley & Sons Ltd
Other Related Docs
13. Relation Between Resveratrol and Diabetes, Journal of Isfahan Medical School (2014)